The histone deacetylase inhibitor valproic acid lessens NK cell action against oncolytic virus-infected glioblastoma cells by inhibition of STAT5/T-BET signaling and generation of gamma interferon.
about
Exploiting tumor epigenetics to improve oncolytic virotherapyOncolytic viruses as therapeutic cancer vaccinesOvercoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint BlockadeFrom scourge to cure: tumour-selective viral pathogenesis as a new strategy against cancerOncolytic herpes simplex virus-based strategies: toward a breakthrough in glioblastoma therapyHistone deacetylase inhibitor romidepsin induces HIV expression in CD4 T cells from patients on suppressive antiretroviral therapy at concentrations achieved by clinical dosing.Cellular factors promoting resistance to effective treatment of glioma with oncolytic myxoma virus.STAT3 activation promotes oncolytic HSV1 replication in glioma cells.Production of bioactive soluble interleukin-15 in complex with interleukin-15 receptor alpha from a conditionally-replicating oncolytic HSV-1Histone deacetylase inhibitors improve the replication of oncolytic herpes simplex virus in breast cancer cellsTumor Selectivity of Oncolytic Parvoviruses: From in vitro and Animal Models to Cancer Patients.Unlocking the promise of oncolytic virotherapy in glioma: combination with chemotherapy to enhance efficacyComplex Dynamics of Virus Spread from Low Infection Multiplicities: Implications for the Spread of Oncolytic Viruses.Combinatorial strategies for oncolytic herpes simplex virus therapy of brain tumors.Epigenetic suppression of the antitumor cytotoxicity of NK cells by histone deacetylase inhibitor valproic acid.Synergistic combination of valproic acid and oncolytic parvovirus H-1PV as a potential therapy against cervical and pancreatic carcinomasA combinational therapy of EGFR-CAR NK cells and oncolytic herpes simplex virus 1 for breast cancer brain metastases.DNA demethylating agents synergize with oncolytic HSV1 against malignant gliomasHistone deacetylase inhibitors potentiate vesicular stomatitis virus oncolysis in prostate cancer cells by modulating NF-κB-dependent autophagyValproic acid for the treatment of malignant gliomas: review of the preclinical rationale and published clinical results.Novel immune modulators used in hematology: impact on NK cellsOncolytic vaccines.Evolution of oncolytic viruses: novel strategies for cancer treatment.STAT5 acetylation: Mechanisms and consequences for immunological control and leukemogenesis.Oncolytic viruses and their application to cancer immunotherapyChemotherapy and Oncolytic Virotherapy: Advanced Tactics in the War against Cancer.Pharmacological modulation of anti-tumor immunity induced by oncolytic viruses.Anti-Epileptic Drug Targets Ewing Sarcoma.Immune Suppression during Oncolytic Virotherapy for High-Grade Glioma; Yes or No?Role of NK cells in immunotherapy and virotherapy of solid tumors.Histone deacetylase inhibitors enhance CD1d-dependent NKT cell responses to lymphomaInduction of Glycosphingolipid GM3 Expression by Valproic Acid Suppresses Cancer Cell Growth.Histone deacetylase inhibitors as immunomodulators in cancer therapeutics.Combination of the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus as a new option for epi-virotherapeutic treatment of hepatocellular carcinoma.Combining HDAC inhibitors with oncolytic virotherapy for cancer therapy.Interferon-Mediated Tumor Resistance to Oncolytic Virotherapy.Reolysin and Histone Deacetylase Inhibition in the Treatment of Head and Neck Squamous Cell Carcinoma.The histone deacetylase inhibitor valproic acid enhances equine herpesvirus type 1 (EHV-1)-mediated oncolysis of human glioma cells.Involvement of the JAK-STAT pathway in collagen regulation of decidual NK cells.Regulation of Human Natural Killer Cell IFN-γ Production by MicroRNA-146a via Targeting the NF-κB Signaling Pathway.
P2860
Q21131237-533F9093-5DEE-4106-9896-DE3827DD5698Q21245758-9990A653-689D-4B32-AE3B-320419F6A8D4Q26769977-04E0647F-374B-4A80-A9BE-E6A476741AD8Q26822694-8578187B-91D4-4F17-9C5D-6DCABF1FB938Q26998111-57B597CD-6727-4C57-B0FE-4FB3807E1188Q28537694-1B4619F0-FDB9-473E-87CF-E6E5F07E3497Q30395978-FBC4BB25-F4F6-4960-8FF4-3E4E5EDD691DQ34927140-3EF75230-09FA-4A6C-980D-2BB97A5765E9Q35060701-41956AA1-CE2E-4AEA-9760-3597849B78FAQ35126723-77BC45AA-20B3-4FCF-B1A8-466FBD5B7CB4Q35522211-88F4199D-524E-4DA4-99B1-D8A81202A230Q35657822-E7409DC5-3F34-400C-B1E6-F0FF4A2A32B6Q36255281-732FA57A-CB5F-4112-8B67-B42EB605AC88Q36849213-B084A1DA-C4B1-447A-9892-B95C7B0F7935Q36853857-EDA2018D-4E9F-4715-AF9A-2B51163DA38AQ37237124-D2DB31E8-BD10-47C6-B761-317C2AF0FC03Q37317390-4318C4F8-B64F-435B-813A-073CD5DD371FQ37386851-0BAD0F02-F55F-4596-B242-1C51E3B83FBDQ37644099-1B94FBDB-F58D-47E6-8B23-12573A479492Q38016227-8E285778-5E22-4035-8E3F-C9EEDA4D119CQ38073760-0C6D8CCA-0796-407A-B2D6-55A8469F3B38Q38152474-DB9853BF-1759-4D79-AF15-F28E12E23783Q38159802-C14F68DC-A041-4141-9968-90917889B251Q38177821-15EDB44C-9A6C-4338-957C-C89FFD5E98B2Q38207011-B1BE3D0B-E315-4CC9-A155-559EEC419FD4Q38223419-040B35DD-8F73-4DCB-B184-F84A732CE2D6Q38237657-8EF62331-6CB0-4BCB-B74B-390D999FED77Q38301170-0CFF9810-E1AC-4013-B9E0-86BFDE855E89Q38348844-B1788ADE-99FD-4E9B-835F-62A788EB30CBQ38575116-9F356759-BCBE-4C91-B527-A864E21B1B12Q38740003-6B0D55E5-CC02-417E-A542-6D6F538E7121Q38751134-B311C738-969A-4C28-A119-6E7769E83C39Q38763747-57C298C1-9FEC-4A9E-B626-84493568AED9Q38845173-4A93320E-3D47-4EF1-BE50-095AABC6B85AQ38924569-AC72470C-2F3E-460A-8617-E5F8B9A990BFQ39109430-4DE6994F-FCA6-4FA9-9AAD-8B806762C110Q40081751-DEB06620-203A-43E3-9391-0968F257D77BQ43778531-2F10281B-16B5-4124-A61B-F98A768A7A0DQ48248124-10B25856-C165-47A4-89C1-D59380E43A3BQ52624503-F08FB86B-FDE2-40D0-81F0-4C5E8B4520FC
P2860
The histone deacetylase inhibitor valproic acid lessens NK cell action against oncolytic virus-infected glioblastoma cells by inhibition of STAT5/T-BET signaling and generation of gamma interferon.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The histone deacetylase inhibi ...... eneration of gamma interferon.
@en
The histone deacetylase inhibi ...... eneration of gamma interferon.
@nl
type
label
The histone deacetylase inhibi ...... eneration of gamma interferon.
@en
The histone deacetylase inhibi ...... eneration of gamma interferon.
@nl
prefLabel
The histone deacetylase inhibi ...... eneration of gamma interferon.
@en
The histone deacetylase inhibi ...... eneration of gamma interferon.
@nl
P2093
P2860
P356
P1433
P1476
The histone deacetylase inhibi ...... eneration of gamma interferon.
@en
P2093
Balveen Kaur
Christine Hwang
Christopher A Alvarez-Breckenridge
E Antonio Chiocca
Jianhua Yu
Michael A Caligiuri
Michal O Nowicki
Richard Price
Soledad A Fernandez
P2860
P304
P356
10.1128/JVI.05545-11
P407
P577
2012-02-08T00:00:00Z